Trial · NCT06889454
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
NCT06889454, Recruiting, Attikon Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS. Trials, record NCT06889454. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06889454
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
- NCT number
- NCT06889454
- Status
- Recruiting
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Attikon Hospital
- Conditions
- PCOS, Hyperinsulinism, Hyperandrogenism, Metabolic Syndrome
- Interventions
- GLP-1 receptor agonist, Oral contraceptive, Metformin, Lifestyle modification
- First posted
- 2025-03-21
- Last updated
- 2025-11-19
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Τhe change in Global Longitudinal Strain during Oral glucose Tolerance Test | 120 minute of Oral glucose Tolerance Test | Τhe change in Global Longitudinal Strain at 0 and 120 minute after glucose load |
| Primary | The change in Pulse Wave Velocity during Oral glucose Tolerance Test | 120minute of Oral glucose Tolerance Test | The change in Pulse Wave Velocity at 0 and 120 minute after glucose load |
| Primary | The change in Perfused Boundary Region during Oral glucose Tolerance Test | 120minute of Oral glucose Tolerance Test | The change in Perfused Boundary Region at 0 and 120 minute after glucose load |
| Primary | The change in Global Longitudinal Strain | six months | The change in Global Longitudinal Strain 6 months after treatment intervention |
| Primary | The change in Pulse Wave Velocity | six months | The change in Pulse Wave Velocity 6 months after treatment intervention |
| Primary | The change in Perfused Boundary Region | six months | The change in Perfused Boundary Region 6 months after treatment intervention |
| Primary | The change in Metalloproteinase 9 | six months | The change in Metalloproteinase 9 six months after tretament intervention |
| Secondary | Τhe change in Coronary flow reserve during Oral glucose Tolerance Test | 120 min of Oral glucose Tolerance Test | Τhe change in Coronary flow reserve at 0 and 120 min after glucose load |
| Secondary | Τhe change in Flow mediated Dilation during Oral glucose Tolerance Test | 120min of Oral glucose Tolerance Test | Τhe change in Flow mediated Dilation at 0 and 120 min after glucose load |
| Secondary | The change in Coronary flow reserve | six months | The change in Coronary flow reserve 6 months after treatment intervention |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06889454
GET https://conductscience.org/api/trials/v1/NCT06889454/registered